Clearmind Medicine (CMND) Stock Research

Today

Clearmind Medicine reports MEAI development program permeation study results

CMND

8:27 AM

Thursday

Psychedelic: Compass Pathways, GH Research report quarterly earnings

Aug 6, 10:23 AM

Clearmind Medicine reports DSMB approves advancing Phase I/II AUD study

CMND

Aug 6, 9:46 AM

Over a week ago

Psychedelic: Clearmind reports safety findings for CMND-100

Jul 30, 10:43 AM

Clearmind Medicine announces safety results from Part A of CMND-100 tral

CMND

Jul 30, 9:41 AM

Clearmind Medicine completes Part A of CMND-100 trial

CMND

Jul 28, 7:51 AM

Psychedelic: PharmAla enters license agreement with Jupiter Neurosciences

Jul 23, 11:05 AM

Clearmind files psychedelic patent application with Hong Kong Patent Office

CMND

Jul 20, 7:57 AM

Clearmind reports positive retention results for intranasal formulation of MEAI

CMND

Jul 16, 9:32 AM

FDA announces availability of final guidance for psychedelic drug research

Jul 15, 11:10 AM

Clearmind Medicine submits response to HHS request for information

CMND

Jul 10, 8:36 AM

Psychedelic: Compass Pathways reports six-month data for psilocybin drug

Jul 9, 9:48 AM

Psychedelic: Helus Pharma reports FY26 financial results

Jul 2, 9:56 AM

Psychedelic: Definium soars on study results for LSD-based depression treatment

Jun 25, 10:14 AM

Clearmind completes treatment for all participants in Part A of CMND-100 trial

CMND

Jun 22, 9:18 AM

Psychedelic: Clearmind completes Part A dosing for Phase I/II CMND-100 trial

Jun 18, 9:57 AM

Clearmind Medicine granted U.S. patent for Binge Behavior Regulators

CMND

Jun 18, 8:03 AM

Clearmind Medicine completes dosing for four cohorts of CMND-100 trial

CMND

Jun 16, 7:42 AM

Psychedelic: Enveric initiates IND-enabling genotoxicity studies of EB-003

Jun 4, 10:57 AM

Clearmind Medicine files Japanese patent application for 5-Methoxy-2-aminoindan

CMND

May 29, 9:03 AM

Psychedelic: Optimi Health advances natural psilocybin extract

May 28, 10:19 AM

Clearmind Medicine announces JHM-IRB approval to advance CMND-100 trial

CMND

May 26, 8:39 AM

Psychedelic: Enveric, NRx, Bright Minds report quarterly earnings

May 21, 11:26 AM

Clearmind Medicine Inc trading halted, news pending

CMND

May 20, 7:50 PM

Clearmind Medicine announces 1-for-10 reverse share split

CMND

May 19, 6:09 AM